Related Experiment Video
Updated: Oct 12, 2025

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.6K
Left Atrial Appendage Closure During Cardiac Surgery for Atrial Fibrillation: A Meta-Analysis.
Rohan Madhu Prasad1, Yehia Saleh2, Abdullah Al-Abcha1
1Department of Internal Medicine, Michigan State University, East Lansing, MI, USA.
Summary
Left atrial appendage closure (LAAC) in atrial fibrillation (AF) patients undergoing cardiac surgery reduces stroke risk and long-term mortality. This procedure showed no significant increase in major bleeding or rehospitalizations.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia associated with increased stroke risk.
- Left atrial appendage closure (LAAC) is a strategy to reduce stroke in AF patients.
- The efficacy and safety of LAAC during cardiac surgery remain under investigation.
Purpose of the Study:
- To comprehensively review and analyze studies comparing LAAC with no LAAC during cardiac surgery in AF patients.
- To evaluate the impact of LAAC on postoperative stroke/embolic events, mortality, and safety outcomes.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials and observational studies.
- Inclusion of studies comparing LAAC to a placebo or no LAAC group in AF patients undergoing cardiac surgery.
- Random-effect model used to calculate risk ratios and confidence intervals.
Main Results:
- LAAC significantly decreased postoperative stroke/embolic events in all cardiac surgeries and isolated valvular surgery.
- Coronary artery bypass grafting (CABG) showed a non-significant trend favoring LAAC for stroke reduction.
- LAAC demonstrated significantly lower two-year all-cause mortality, with no difference in perioperative mortality, major bleeding, or rehospitalizations.
Conclusions:
- LAAC during cardiac surgery in AF patients is associated with a reduced risk of stroke and long-term mortality.
- The procedure does not increase major bleeding, all-cause rehospitalizations, or cross-clamp time.
- LAAC is a safe and effective adjunctive therapy for stroke prevention in AF patients undergoing cardiac surgery.

